Q4 drug prices average slight decreases, few changes to end year

Article Overview

This article covers CMS’s fourth-quarter average sales price (ASP) update for Medicare drug reimbursement, with a focus on broad payment trends, the volume of increases and decreases, and a few code-level changes that affected the quarterly list. It also explains the status of CMS’s longer-term transition from ASP-based pricing to AMP-based pricing and why the current approach remains in place. The piece is relevant to billing and reimbursement professionals who track drug pricing updates, quarterly Medicare changes, and HCPCS drug-code activity.